Pharmacists play a crucial role in managing myelofibrosis, enhancing patient education, adherence, and financial navigation for optimal care.
Jessica Lewis-Gonzalez, PharmD, BCOP
Advertisement
Articles by Jessica Lewis-Gonzalez, PharmD, BCOP
Balancing Efficacy and Safety: Navigating Dose Adjustments and Therapy Optimization in Myelofibrosis
Jessica Lewis-Gonzalez, PharmD, BCOP, discusses the management of hematologic and non-hematologic toxicities in cancer patients, emphasizing the importance of proactive monitoring and collaboration between clinicians and pharmacists.
Jessica Lewis-Gonzalez, PharmD, BCOP, discusses the challenges of managing myelofibrosis, from its heterogeneity and symptom burden to limited curative options.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times - Pharmacy Practice News and Expert Insights
1
Understanding RSV in Older Adults: Risks, Symptoms, and Barriers to Vaccination
2
Patients Critically Ill With COVID-19 Have Heightened Risk of Pulmonary Fibrosis
3
Study Finds CGMs Could Overestimate Food’s Impact on Blood Sugar Among Nondiabetic Individuals
4
Pharmacists Can Provide Trusted Medical Advice in an Era of Fractured Health Care
5
